Abstract:Humanization is a critical process for designing efficiently specific antibodies and nanobodies prior to clinical trials. Developing widely recognized deep learning techniques or frameworks for humanizing conventional antibodies and nanobodies presents a valuable yet challenging task. Inspired by the effectiveness of diffusion models across various applications, we introduce HuDiff, an adaptive diffusion approach for humanizing antibodies and nanobodies from scratch, referred to as HuDiff-Ab and HuDiff-Nb, respectively. This approach begins the humanization process exclusively with complementarity-determining region (CDR) sequences, eliminating the need for humanized templates. On public benchmark datasets, the results of HuDiff-Ab's humanized antibodies are more similar to experimentally humanized antibodies than to those of the Sapiens humanization model. Besides, humanized nanobodies produced by HuDiff-Nb exhibit a higher humanness score and greater nativeness than those generated by the Lammanade pipeline for humanization nanobody. We apply HuDiff to humanize a mouse antibody and an alpaca nanobody, both targeting the SARS-CoV-2 RBD, and validate the binding affinity of humanized sequences through Bio-Layer Interferometry (BLI) experiments. The results show the binding affinity of the best humanized antibody is nearly equal to that of the parental mouse antibody (0.15 nM vs. 0.12 nM). Remarkably, the top-performing humanized nanobody exhibits a significantly enhanced binding affinity compared to the parental alpaca nanobody (2.52 nM vs. 5.47 nM), representing a 54% increase. These findings indicate that our approach HuDiff is highly effective in enhancing the humanness of antibodies and nanobodies while maintaining or potentially improving the binding affinity of the designed humanized sequences. The code and checkpoints of HuDiff are available at https://github.com/TencentAI4S/HuDiff.

AntiBARTy Diffusion for Property Guided Antibody Design

Guiding diffusion models for antibody sequence and structure co-design with developability properties

BetterBodies: Reinforcement Learning guided Diffusion for Antibody Sequence Design

Retrieval Augmented Diffusion Model for Structure-informed Antibody Design and Optimization

AI-driven antibody design with generative diffusion models: current insights and future directions

AbDiffuser: Full-Atom Generation of in vitro Functioning Antibodies

AbGPT: De Novo Antibody Design via Generative Language Modeling

AB-Gen: Antibody Library Design with Generative Pre-trained Transformer and Deep Reinforcement Learning

Antibody DomainBed: Out-of-Distribution Generalization in Therapeutic Protein Design

Benchmarking Generative Models for Antibody Design & Exploring Log-Likelihood for Sequence Ranking

Antibody-SGM, a Score-Based Generative Model for Antibody Heavy-Chain Design

Computational design of developable therapeutic antibodies: efficient traversal of binder landscapes and rescue of escape mutations

Antibody Library Design by Seeding Linear Programming with Inverse Folding and Protein Language Models

Generative Humanization for Therapeutic Antibodies

Addressing the antibody germline bias and its effect on language models for improved antibody design

IgGM: A Generative Model for Functional Antibody and Nanobody Design

De novo antibody design with SE(3) diffusion

Unlocking antibody design with generative artificial intelligence

Antibody optimization enabled by artificial intelligence predictions of binding affinity and naturalness

An adaptive autoregressive diffusion approach to design active humanized antibody and nanobody